Did Solazyme just patent an algal treatment for diabetes?

Inform Smartbrief reports that Solazyme has been issued US Patent #8,747,834 describing the use of algal biomass as a treatment for impaired glucose metabolism. Solazyme’s natural strain of algae…

Algae 101: Part 46

The cost of diabetes in the US approaches $200 billion annually. A new study released at the “Weight of the Nation” conference in Washington DC in April 2012 predicts 42% of Americans will be obese by 2030. Either we solve diabetes…